- Development of a clinicomolecular risk stratification system for nonmetastatic nasopharyngeal carcinoma using Epstein-Barr virus DNA and TNM stage: A "Big data" analysis of 9,160 endemic cases.Chen, Fo-Ping; Zhou, Guan-Qun; Luo, Ying-Shan; Tan, Kuan Rui Lloyd; Tan, Sze Huey; Zheng, Yu; Lin, Li; Guo, Ying; Ma, Jun; Chua, Melvin L. K.; Sun, YingAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2019-05-31 To 2019-06-04.
- Longitudinal circulating Epstein-Barr virus DNA response to induction chemotherapy and chemo-radiotherapy to identify biological phenotypes in EBV-associated nasopharynx of head and neck cancer.Lv, Jia-Wei; Sun, Ying; Chen, Yu-Pei; Zhou, Guan-Qun; Tan, Kuan Rui Lloyd; Ma, Jun; Chua, Melvin L. K.Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2019-05-31 To 2019-06-04.
- Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.Chan K C Allen; Woo John K S; King Ann; Zee Benny C Y; Lam W K Jacky; Chan Stephen L; Chu Sam W I; Mak Constance; Tse Irene O L; Leung Samantha Y M; Chan Gloria; Hui Edwin P; Ma Brigette B Y; Chiu Rossa W K; Leung Sing Fai; van Hasselt Andrew C; Chan Anthony T C; Lo Y M DennisN Engl J Med, 2017, 377(6): 513-522.
期刊论文
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.
12阅读
